Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 9:58 PM
Ignite Modification Date: 2025-12-25 @ 7:36 PM
NCT ID: NCT02026232
Description: None
Frequency Threshold: 5
Time Frame: Adverse events will be monitored during the study -- approximately 1 month of study participation
Study: NCT02026232
Study Brief: Metabolic Effects of Hydroxychloroquine
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Hydroxychloroquine hydroxychloroquine twice daily for 4 weeks Hydroxychloroquine: 200mg twice daily 0 None 0 10 3 10 View
Placebo hydroxychloroquine placebo twice daily for 4 weeks Hydroxychloroquine Placebo: 200mg placebo twice daily 0 None 0 11 1 11 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Drop in hematocrit SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View